Close
  Indian J Med Microbiol
 

Figure 3: Effect of treatment on expression of (A) HLA-DR, (B) CD83, (C) CD80 and (D) CD86 on monocyte-derived dendritic cells (mo-DCs) from chronic hepatitis-C patient (CHC)-II pre and post-treatment (in terms of fold increase in mean fluorescence intensity, MFI). Expression of all molecules increases significantly in SVR+ although no change is seen in SVR- patients. SVR, sustained virology response. (Reproduced with permission from John Wiley and Sons Ltd., Philadelphia, USA [Liver Int 2012; 32 : 1128-37]68.

Figure 3: Effect of treatment on expression of (A) HLA-DR, (B) CD83, (C) CD80 and (D) CD86 on monocyte-derived dendritic cells (mo-DCs) from chronic hepatitis-C patient (CHC)-II pre and post-treatment (in terms of fold increase in mean fluorescence intensity, MFI). Expression of all molecules increases significantly in SVR+ although no change is seen in SVR- patients. SVR, sustained virology response.
(Reproduced with permission from John Wiley and Sons Ltd., Philadelphia, USA [<i>Liver Int</i> 2012; <i>32</i> : 1128-37]<sup>68</sup>.